Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert L Atmar

Showing results (161-170 of 237) with videos related to

Pageof 24
Sort By:
Open Forum Infectious Diseases|April 6, 2019
Active Surveillance for Norovirus in a US Veterans Affairs Patient Population, Houston, Texas, 2015-2016Anita K Kambhampati, Blanca Vargas, Mahwish Mushtaq, et al.
Vaccine|July 7, 2009
Safety and immunogenicity of a subvirion inactivated influenza A/H5N1 vaccine with or without aluminum hydroxide among healthy elderly adultsRebecca C Brady, John J Treanor, Robert L Atmar, et al.
Nature Communications|February 28, 2023
CLIC and membrane wound repair pathways enable pandemic norovirus entry and infectionB Vijayalakshmi Ayyar, Khalil Ettayebi, Wilhelm Salmen, et al.
The New England Journal of Medicine|December 14, 2011
Norovirus vaccine against experimental human Norwalk Virus illnessRobert L Atmar, David I Bernstein, Clayton D Harro, et al.
Clinical and Vaccine Immunology : CVI|March 3, 2017
B-Cell Responses to Intramuscular Administration of a Bivalent Virus-Like Particle Human Norovirus VaccineSasirekha Ramani, Frederick H Neill, Jennifer Ferreira, et al.
Journal of Clinical Microbiology|March 23, 2010
Noroviruses as a cause of diarrhea in travelers to Guatemala, India, and MexicoHoonmo L Koo, Nadim J Ajami, Zhi-Dong Jiang, et al.
The Journal of Infectious Diseases|February 15, 2007
Reducing the dose of smallpox vaccine reduces vaccine-associated morbidity without reducing vaccination success rates or immune responsesRobert B Couch, Patricia Winokur, Kathryn M Edwards, et al.
Vaccine|September 30, 2025
SARS-CoV-2 spike sequence-based distance as a marker of binding antibody response to COVID-19 vaccinesClara P Dominguez Islas, Craig A Magaret, Cindy Molitor, et al.
Msphere|January 28, 2021
New Insights and Enhanced Human Norovirus Cultivation in Human Intestinal EnteroidsKhalil Ettayebi, Victoria R Tenge, Nicolas W Cortes-Penfield, et al.
Clinical and Vaccine Immunology : CVI|October 5, 2012
Antibody responses to norovirus genogroup GI.1 and GII.4 proteases in volunteers administered Norwalk virusNadim J Ajami, Meagan A Barry, Berenice Carrillo, et al.
Pageof 24

Showing results (161-170 of 237) with videos related to

Sort By:
Pageof 24
Open Forum Infectious Diseases|April 6, 2019
Active Surveillance for Norovirus in a US Veterans Affairs Patient Population, Houston, Texas, 2015-2016Anita K Kambhampati, Blanca Vargas, Mahwish Mushtaq, et al.
Vaccine|July 7, 2009
Safety and immunogenicity of a subvirion inactivated influenza A/H5N1 vaccine with or without aluminum hydroxide among healthy elderly adultsRebecca C Brady, John J Treanor, Robert L Atmar, et al.
Nature Communications|February 28, 2023
CLIC and membrane wound repair pathways enable pandemic norovirus entry and infectionB Vijayalakshmi Ayyar, Khalil Ettayebi, Wilhelm Salmen, et al.
The New England Journal of Medicine|December 14, 2011
Norovirus vaccine against experimental human Norwalk Virus illnessRobert L Atmar, David I Bernstein, Clayton D Harro, et al.
Clinical and Vaccine Immunology : CVI|March 3, 2017
B-Cell Responses to Intramuscular Administration of a Bivalent Virus-Like Particle Human Norovirus VaccineSasirekha Ramani, Frederick H Neill, Jennifer Ferreira, et al.
Journal of Clinical Microbiology|March 23, 2010
Noroviruses as a cause of diarrhea in travelers to Guatemala, India, and MexicoHoonmo L Koo, Nadim J Ajami, Zhi-Dong Jiang, et al.
The Journal of Infectious Diseases|February 15, 2007
Reducing the dose of smallpox vaccine reduces vaccine-associated morbidity without reducing vaccination success rates or immune responsesRobert B Couch, Patricia Winokur, Kathryn M Edwards, et al.
Vaccine|September 30, 2025
SARS-CoV-2 spike sequence-based distance as a marker of binding antibody response to COVID-19 vaccinesClara P Dominguez Islas, Craig A Magaret, Cindy Molitor, et al.
Msphere|January 28, 2021
New Insights and Enhanced Human Norovirus Cultivation in Human Intestinal EnteroidsKhalil Ettayebi, Victoria R Tenge, Nicolas W Cortes-Penfield, et al.
Clinical and Vaccine Immunology : CVI|October 5, 2012
Antibody responses to norovirus genogroup GI.1 and GII.4 proteases in volunteers administered Norwalk virusNadim J Ajami, Meagan A Barry, Berenice Carrillo, et al.
Pageof 24